Searched for
BUY AUROBINDO PHARMA LTD
Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities rallied sharply as an interim US-Iran peace framework eased geopolitical concerns and pushed oil prices lower. Improved inf...
- Bitcoin holds near $64,000 as falling oil prices and US-Iran peace hopes lift risk sentimentBitcoin hovered near $64,000, buoyed by falling oil prices and optimism for a US-Iran peace deal, which lifted overall risk sentiment. Whil...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Pharma exports to US seen muted this yearIndian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are ...
- Ahead of Market: 10 things that will decide stock market action on ThursdayBenchmark indices closed marginally higher on Wednesday, led by gains in banking and auto shares, while IT and FMCG stocks capped advances....
- Pharma, NBFCs see fresh mutual fund buying in AprilIndian fund managers focused on defensive stocks in April. Pharmaceuticals saw increased investment due to opportunities like the semagluti...
- Buy capital goods on dips, stay cautious on IT and consumption: Sudip BandyopadhyayMarket expert Sudip Bandyopadhyay outlines investment strategies across key sectors. He sees opportunities in State Bank of India and a gen...
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- Another buyback offer coming soon! This time it's from Bajaj AutoBajaj Auto has announced that its board will consider a share buyback proposal on May 6, 2026, signalling plans to return surplus cash to s...
- Aurobindo Pharma's Rs 800 cr buyback closes this week: Should you tender shares?Aurobindo Pharma has initiated a share buyback program valued at Rs 800 crore, set to remain open until April 29. The company aims to reacq...
- Stocks in news: SBI Life, Trent, Tata Investment, HCL Tech, Suzlon EnergyIn today's trade, shares of SBI Life, Trent, Tata Investment, HCL Tech, Suzlon Energy among others will be in focus due to various news dev...
- Aurobindo Pharma announces schedule, record date for its Rs 800 crore share buybackAurobindo Pharma has announced an Rs 800 crore share buyback via the tender route, offering Rs 1,475 per share. The buyback opens April 23 ...
- Buyback alert! Last date to buy Aurobindo Pharma shares for Rs 800-crore share buyback. Check detailsAurobindo Pharma has announced an ₹800-crore buyback at ₹1,475 per share, with April 17, 2026 set as the record date—meaning investors must...
- Share buybacks this month: Wipro, Aurobindo Pharma, 2 other stocks to watch out forFour companies—Wipro, Cyient, Windlas Biotech, and Aurobindo Pharma—are set to announce or act on share buybacks this month, with Aurobindo...
- Aurobindo Pharma approves Rs 800 crore share buyback. Check record date, other key detailsAurobindo Pharma is launching its first share buyback in two years, offering to repurchase over 54 lakh shares at Rs 1,475 each. This tende...
- Buy Aurobindo Pharma, target price Rs 538: Nuvama WealthBreakout above its falling 200 DMA after a gap oftwo years adding to the bullish conviction.
- Buy Aurobindo Pharma Ltd. with target of Rs 1200: Mitesh Thacker"Aurobindo Pharma Ltd is a 'BUY' call with a target of Rs 1200 and a stop loss of Rs 1140."
- Buy Aurobindo Pharma with a target of Rs 1167: Prakash Gaba"Aurobindo Pharma is a 'BUY' call with a target of Rs 1167 and a stop loss of Rs 1129."
- Buy Aurobindo Pharma with a target of Rs 770: Prakash GabaAurobindo Pharma is a 'BUY' call with a target of Rs 770 and a stop loss of Rs 725.
Load More
